Equity

IHE

iShares U.S. Pharmaceuticals ETF

Overview

Loading

Performance

Performance

Growth of Hypothetical 10,000

Performance chart data not available for display.
View full chart

Distributions

Ex-Date Total Distribution Income
View full table

Premium/Discount

  1Y 3Y 5Y 10y Incept.
18.53 2.80 3.46 11.87 10.10
Market Price (%) 18.71 2.86 3.51 11.89 10.11
Benchmark (%) 19.04 3.08 3.76 12.24 10.53
After Tax Pre-Liq. (%) 18.12 2.48 3.10 11.53 9.80
After Tax Post-Liq. (%) 11.20 2.12 2.65 9.88 8.54
  YTD 1m 3M 6M 1Y 3Y 5Y 10y Incept.
3.15 -1.94 6.66 21.92 18.53 8.65 18.55 207.08 300.68
Market Price (%) 3.28 -1.98 6.89 22.03 18.71 8.84 18.83 207.63 301.19
Benchmark (%) 3.49 -1.91 6.77 22.21 19.04 9.54 20.27 217.32 323.12
After Tax Pre-Liq. (%) 2.88 -2.05 6.55 21.73 18.12 7.61 16.51 197.90 285.17
After Tax Post-Liq. (%) 2.02 -1.08 4.02 13.10 11.20 6.48 13.95 156.52 225.95
  2015 2016 2017 2018 2019
Total Return (%) 8.81 -11.72 10.66 -7.67 15.49
Market Price (%) 8.86 -11.66 10.59 -7.65 15.45
Benchmark (%) 9.39 -11.42 10.90 -7.56 15.86
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Key Facts

Key Facts

Net Assets as of Oct 30, 2020 USD 343,137,539
Inception Date May 1, 2006
Exchange NYSE Arca
Asset Class Equity
Benchmark Index Dow Jones U.S. Select Pharmaceuticals Index
Bloomberg Index Ticker DJSPHMT
Shares Outstanding as of Oct 30, 2020 2,150,000
Number of Holdings as of Oct 29, 2020 47
Premium/Discount as of Oct 30, 2020 0.04%
CUSIP 464288836
Closing Market Price as of Oct 30, 2020 159.02
Mid-Point Market Price as of Oct 30, 2020 159.67
Options Available Yes
Premium/Discount as of Oct 30, 2020 -0.36
30 Day Avg. Volume as of Oct 30, 2020 4,268.00
30 Day Median Bid/Ask Spread as of Oct 30, 2020 0.07
Volume - 1d as of Oct 30, 2020 5,228.00

Portfolio Characteristics

Portfolio Characteristics

P/E Ratio as of Oct 29, 2020 23.55
P/B Ratio as of Oct 29, 2020 3.94
Equity Beta (3y) as of Sep 30, 2020 0.87
Standard Deviation (3y) as of Sep 30, 2020 17.94%
12m Trailing Yield as of Sep 30, 2020 1.30%
30 Day SEC Yield as of Sep 30, 2020 1.23%
Unsubsidized 30-Day SEC Yield as of Sep 30, 2020 1.23%

Fees

Fees

as of current prospectus
Management Fee 0.42
Acquired Fund Fees and Expenses 0.00
Foreign Taxes and Other Expenses 0.00
Expense Ratio 0.42
on Dec 31, 2019
Management Fee 0.42
Acquired Fund Fees and Expenses 0.00
Foreign Taxes and Other Expenses 0.00
Expense Ratio 0.42

Holdings

Holdings